Project Grant F30CA298778
Award Date 1/11/26
Completion Date 6/30/26
Dollars Obligated $104K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Texas, USA
Similar Awards
- This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) provides $371,161 to develop advanced AI-based risk models for cervical cancer screening in low-resource settings. The project aims to leverage time-series imaging data and self-supervised learning to enhance the diagnostic accuracy of automated visual evaluation (AVE) models. The goal is to create a comprehensive risk stratification system that combines imaging data, HPV...
- This federal Project Grant award of $317,420 from the National Cancer Institute's Cancer Detection and Diagnosis Research program (CFDA 93.394) aims to develop and validate a patient-ready callascope device for cervical imaging and cancer prevention in low- and middle-income countries (LMICs). The primary focus is on creating point-of-care solutions for screening, diagnosis, and treatment that can be delivered by community health workers and midwives, thereby increasing access to care. Key...
- The University of Alabama at Birmingham (UAB) received a $192,780 Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower program) to implement and optimize a bundled screening program for breast and cervical cancer in a resource-limited setting in sub-Saharan Africa. The project aims to 1) establish the reach and effectiveness of the bundled screening program across stationary and mobile clinics, and 2) identify the implementation outcomes of...
- This federal Project Grant award, valued at $306,872 and provided by the National Cancer Institute under the Cancer Treatment Research program (CFDA 93.395), aims to develop a new imaging system termed the Multi-Camera Array Scanner (MCAS). The MCAS will enable rapid 3D digitization and automated analysis of thick fine-needle aspiration (FNA) cytology smears, which are a critical first step in the cancer diagnosis pipeline. The project is a collaboration between Ramona Optics Inc., a small...
- This Project Grant, awarded by the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research), provides $627,148.00 to the University of Maryland, College Park to develop an injectable, low-cost ablative therapy based on ethyl cellulose-ethanol gel for treating cervical dysplasia. The goal is to create an alternative to current costly and technically complex cervical cancer prevention solutions that are not practical for use in medically underserved regions. The project...
- This Project Grant award for $402,728, provided by the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394), aims to develop innovative deep learning models for multi-modal imaging analysis to improve the accuracy and interpretability of gastric cancer prognosis. The primary goal is to leverage Computed Tomography (CT) and whole-slide pathological images (WSI) to create interpretable deep learning models that can provide more accurate and...
- This $593,383 Project Grant, awarded by the National Cancer Institute under the Cancer Detection and Diagnosis Research program (CFDA 93.394), is supporting the development of an AI-augmented, multimodal, label-free nonlinear optical microscopy system for rapid and precise diagnosis of thyroid cancer and lymph node metastasis. The primary awardee, The Methodist Hospital Research Institute, is collaborating with The Johns Hopkins University on this project. The proposed system aims to eliminate...
- This Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) supports research by the University of Texas MD Anderson Cancer Center to develop a Globally Accessible and Pragmatic Predictive Signature (GAPPS) for risk stratification of patients with locally advanced cervical cancer. The $498,565 award is intended to address the need for evidence-based, globally applicable early-treatment biomarkers to optimize radiation...
- This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $442,750.00 to New York University (NYU) to conduct a study on implementation strategies for cervical cancer control policies in Africa. The project aims to: (A) Engage a network of experts from African low- and middle-income countries (LMICs) and global agencies through a Delphi process to identify determinants of policy implementation success, using the Consolidated...
- The National Cancer Institute awarded a $717,667 Project Grant titled "Artificial Intelligence Enabled Stroma-Weighted Automated Grading System to Improve Risk Stratification in Black Men" under the Cancer Detection and Diagnosis Research program (CFDA 93.394). The grant aims to develop an AI-enabled automated grading system that leverages multiphoton microscopy and second harmonic generation imaging to analyze prostate cancer tumor biology and improve risk stratification, particularly...